Return to search

TenSixteen Bio garners $40m

TenSixteen Bio, which is focused on treating age-related diseases at earlier stages, has raised $40 million in funding.

TenSixteen Bio, which is focused on treating age-related diseases at earlier stages, has raised $40 million in funding. The investors were Foresite Capital and GV.

Source: Press Release